NIAGARA FALLS, N.Y.–(BUSINESS WIRE)–Cabbacis Inc (“Cabbacis” or the “Company”), a U.S. federally-licensed tobacco product manufacturer and plant biotech company focused on harm reduction products, announced today that investors can now participate in the Company’s Regulation A (Tier 2) initial public offering (IPO) through a capital raising portal. The Company has strategically chosen Issuance as its Regulation A, equity crowdfunding, platform portal. The Issuance platform conveniently accept
- SEO Powered Content & PR Distribution. Get Amplified Today.
- PlatoData.Network Vertical Generative Ai. Empower Yourself. Access Here.
- PlatoAiStream. Web3 Intelligence. Knowledge Amplified. Access Here.
- PlatoESG. Carbon, CleanTech, Energy, Environment, Solar, Waste Management. Access Here.
- PlatoHealth. Biotech and Clinical Trials Intelligence. Access Here.
- Source: https://mmpconnect.com/cabbacis-adds-equity-crowdfunding-platform-for-ipo/?utm_source=rss&utm_medium=rss&utm_campaign=cabbacis-adds-equity-crowdfunding-platform-for-ipo